Skip to main content

Table 1 Cuban patients studied (n = 104), according to their genotype for the TaqI polymorphism of the VDR gene and the possibility of a clinical form -whether non symptomatic or symptomatic- compared to the risk of presenting another clinical forms

From: TaqI polymorphism of the VDR gene: aspects related to the clinical behavior of COVID-19 in Cuban patients

Clinical forms

Genotypes for the TaqI polymorphism

tt

Tt

TT

No

OR (IC = 95%)

No

OR (IC = 95%)

No

OR (IC = 95%)

Symptomatic (n = 81)

7

2.081

[0.243–17.842]

34

0.465

[0.180–1.198]

40

1.829

[0.699–4.788]

Non symptomatic (n = 23)

1

0.481

[0.056–4.120]

14

2.150

[0.835–5.541]

8

0.547

[0.209–1.431]

  1. OR: odds ratio
  2. CI: confidence interval